Clinical Significance of Sleep Desaturation in Hypoxemic Chronic Obstructive Pulmonary Disease: Studies in 130 Patients by Conway, William A. et al.
Henry Ford Hospital Medical Journal 
Volume 36 Number 1 Article 6 
3-1988 
Clinical Significance of Sleep Desaturation in Hypoxemic Chronic 
Obstructive Pulmonary Disease: Studies in 130 Patients 
William A. Conway 
Meir Kryger 
Richard M. Timms 
George W. Williams 
Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal 
 Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons 
Recommended Citation 
Conway, William A.; Kryger, Meir; Timms, Richard M.; and Williams, George W. (1988) "Clinical Significance 
of Sleep Desaturation in Hypoxemic Chronic Obstructive Pulmonary Disease: Studies in 130 Patients," 
Henry Ford Hospital Medical Journal : Vol. 36 : No. 1 , 16-23. 
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol36/iss1/6 
This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has 
been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health 
System Scholarly Commons. 
Clinical Significance of Sleep Desaturation in Hypoxemic Chronic 
Obstructive Pulmonary Disease: Studies in 130 Patients 
William A. Conway, MD,* Meir Kryger, MD,+ Richard M. Timms, MD,* and 
George W. Williams, MD§ 
We studied 130 patients with hypoxemic chronic obstructive lung disease to delermine if nocturnal 
desaturation aggravates hypoxia-induced complications. All had tesls of neuropsychological and 
physiological function known to be affected by chronic hypoxia. Ofthe 130 patients, 25 had complete 
polysomnography and 105 had their sleep judged visually and arterial oxygen saturation recorded 
continuously. Severe and mild desaturation groups were defined relative to the mean for both mean and 
maximal sleep desaturation, and the severity of waking complications were compared. No significant 
differences were noled between patients wilh mild and severe mean desaturation or maximal 
desaturation for hematocrit, neuropsychological tests, maximal exercise tolerance, or measures of 
quality of life. Waking pulmonary artery pressure did not differ significanlly ber^'een patients with mild 
and severe mean desaturation or maximal desaturation, except in 20 patients with the mosl severe 
mean desaturation during sleep. We conclude lhal nocturnal desaturation does not aggravate 
hypoxia-induced complications in most patients who are chronically hypoxemic from chronic 
obstructive pulmonary disease. (Henry Ford Hosp Med J 1988:36:16-23) 
A rterial oxygen desaturation occurs frequently during sleep in patients with chronic obstmctive pulmonary disease (COPD) 
(1-7). In some patients, episodes of hypoxemia during sleep are 
prolonged and severe. Causes of hypoxemia include hypoven-
tilation (2,6) and, rarely, episodes of upper airway obstmction 
and central apnea (5,7). Frequently, hypoxemia may occur with-
out any abnormalities in breathing pattems, suggesting altera-
tions in the distribution of ventilation perfusion ratios (1,6). 
Although desaturation has been well described and appears to 
be common, its clinical significance is unclear. Episodes of de-
saturation are accompanied by transient elevations in pulmonary 
artery pressure (8,9), but sustained pulmonary hypertension and 
cor pulmonale have not been causally linked to episodes of sleep 
desaturation. Furthermore, the effect of noctumal desaturation 
on other complications of hypoxia, such as polycythemia, neu-
ropsychological impairment, and exercise intolerance, has not 
been evaluated. To examine the role of sleep desaturation on hy-
poxemia-induced complications, we monitored continuously ar-
terial oxygen saturation (SaO,) during sleep in a well-defined 
population of patients with severe hypoxemic COPD. Our pur-
pose was to determine i f patients with severe noctumal desatura-
tion had more severe complications of chronic hypoxemia than 
those with less severe desaturation and whether routine clinical 
and laboratory features might offer clues to the presence of 
severe sleep desaturation. 
Methods 
Patients 
From the 203 hypoxemic patients enrolled in a multicenter 
noctumal oxygen therapy trial (NOTT), data on 130 who slept 
for more than two hours were selected for analysis. Complete 
entry criteria and methods for the NOTT have been previously 
published (10). All patients had a history compatible with COPD 
and a forced expiratory volume in one second (FEV,) after in-
haled bronchodilators of less than 70% of predicted normal and 
total lung capacity at least 80% of predicted nonnal. To be con-
sidered hypoxemic, a patient had to demonstrate either a partial 
pressure of PaO, of less than 55 mm Hg or a PaO, of less than 59 
mm Hg with either significant ankle edema or ECG evidence of 
p-pulmonale. This degree of hypoxemia had to be maintained 
for at least three weeks of infection-free clinical stability with 
the patient on an intensive bronchodilator regimen. 
Protocol summary 
The following procedures were done within five days after the 
three-week stabilization period: standardized history and physical 
examination, sleep studies, quality of life questionnaires, neuro-
psychological tests, pulmonary function tests, hemodynamic 
measurements, and arterial blood gas measurements. Medical 
records were reviewed to document a history of hospitalization in 
the year preceding the patient's entry into the study and to deter-
mine the reason for each hospitalization. Aspects of quality of life 
were determined by two standard self-report questionnaires: the 
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Profile of Mood States (11), which serves as a measure of current 
mood; and the Sickness Impact Profile (12), which measures 12 cat-
egories of physical and psychosocial activities likely to be affected 
by illness. The latter includes a sleep-rest category which contains 
questions such as "1 sleep less at night, for example, wake up too 
early, awaken frequently," and " I am sleeping or dozing most of the 
time—day and night." During the five days in the hospital, patients 
retired at their normal time and slept until their normal time of aris-
ing. Sleep studies were performed during one night of this hospi-
talization while the patients were breathing room air. All received a 
theophylline preparation and an inhaled beta-adrenergic agonist, 
and none received .sedative or psychotropic dmgs during the study. 
Each patient gave informed consent to the study. 
Sleep recordings 
We performed the sleep studies by two separate methods. In 
the first method, 25 of the patients selected consecutively from 
two centers were studied in a fully equipped sleep laboratory. 
The EEG was recorded with gold-plated surface electrodes ap-
plied at positions C,, C4, A,, and A, (according to the interna-
tional lO-to-20 system) (13). Similar electrodes were applied 
around the eyes to obtain the electrooculogram and under the 
chin to obtain the electromyogram of submental muscles. The 
impedance of the applied electrodes was measured with an elec-
trode imoedance meter (Grass Instrument Co, Quincy, MA) and 
was always less than 10 11. Other variables measured were 
breathing pattern (using inductance pneumography or abdomi-
nal and chest strain gauges), SaO, (using a fiberoptic ear ox-
imeter [Hewlett-Packard]), airflow detection at the nose and 
mouth (using an infrared CO, analyzer, or thermistors), and an 
ECG. The data were recorded on a multichannel polygraph at a 
paper speed of 10 mm/sec. Awake SaO, was obtained during 15 
minutes of supine wakefulness. Mean SaO, (referred to as basal 
sleep SaO,) was obtained for a 30-second period every 2.5 min-
utes throughout the night. We recorded the number of times the 
SaO, reached 10% less than the awake SaO,. The lowest SaO, 
for the entire sleep period was also obtained. 
The second method consisted of studying 105 subjects who 
slept at night in a darkened room with a qualified observer in 
constant attendance. Sleep was judged visually, and SaO, was 
measured by a fiberoptic ear oximeter (Hewlett-Packard) and re-
corded continuously on a single channel recorder. From these 
records, similar measurements were made of awake, basal sleep, 
10% dips, and lowest sleep SaO,. Although we tried to record at 
least four hours of sleep, instrumentation prevented this in some 
cases. All patients were judged to sleep for more than two hours 
during the period they were observed. 
Statistical analysis 
Pairwise associations between variables were examined by 
Pearson correlation coefficients or X" tests as appropriate. The 
relationship between one variable and several others was exam-
ined by multiple regression analysis. Student's rtest was used to 
test the equality of mean values between two groups. Mean val-
ues for two groups were compared after adjustment for a covari-
ate by analysis of covariance (14). The survival experience for 
two groups was compared by the log-rank test (15). In addition 
to these inferential procedures, basic, descriptive information 
Table 1 
Clinical and Physiologic Characteristics of 130 Patients 
with Hypoxemic Chronic Obstructive Pulmonary Disease 
Sleep Recording Method 
Nonpolygraphic Polygraphic 
Characteristics Mean SD Mean SD 
Age (years) 66 8.5 66 8.8 
PaO, (mm Hg) 51.7 4,4 52.4 4.5 
PaCO, (mm Hg) 42.2 7.2 44.7 8.2 
FEV|* (L) 0.75 0.3 0.7 0.4 
Total sleep timet (minutes) 195.5 40.3 256.1 93.4 
Awake supine SaO, (%) 86.2 4.6 87.8 4.7 
Mean sleep SaO, (%) 83.2 6.9 82.9 7.2 
Lowest sleep SaO, (%) 69.1 13.6 69.0 13.2 
Sex (male/female) 83/22 20/5 
*FEV| = forced expiratory volume in one second, 
tp < 0.001; all other differences P > 0.1. 
such as means and standard deviations were provided for the 
most relevant variables. 
Results 
The 105 patients who underwent nonpolygraphic sleep stud-
ies and the 25 patients who were studied with complete poly-
somnography were similar in terms of pulmonary function and 
degree of arterial oxygen desaturation during sleep (Table 1). 
The mean total sleep time was one hour longer in the latter 
group. Rapid eye movement (REM) sleep, recorded in 21 of 
these 25 patients, accounted for 10% of their total sleep time. 
Patients in both groups ranged in age from 41 to 84 years (mean 
65.7 years) and weighed from 40 to 104 kg (mean 64.2 kg). They 
had severe obstmctive lung disease with associated hypoxemia 
and borderline hypercapnia. Their other characteristics were 
similar to those previously recorded for patients enrolled in the 
NOTT (10). 
Terms and definitions 
Desaturation was expressed as either basal desaturation 
(awake SaO, minus mean sleep SaO,) or maximal desaturation 
(awake SaO, minus lowest sleep SaO,). We separated the pa-
tients into severe and mild desaturation groups for both the basal 
and maximal desaturation measures. The groups were defined 
relative to the mean for both basal and maximal desaturation. 
This arbitrary division allowed for approximately equal num-
bers in each group, yet recognized the clustering of patients 
toward a mild degree of desaturation (Figs 1 and 2). The basal 
desaturation during sleep exceeded 3% in 49 patients and was ^ 
3% in 81 patients. Maximal desaturation was ^ 17% in 53 pa-
tients and < 17% in 77 patients. A total of 66 patients had either 
severe basal or severe maximal desaturation, but only half 
(36/66) had severe abnormalities for both measures of desatura-
tion. Because of this divergence, both measures of desaturation 
were analyzed. 
Degree of desaturation during sleep 
The mean awake SaO, ± SD in 130 patients was 86.5% ± 
4.7%. The mean basal desaturation was 3.4% ± 4.0% (Fig 1), 
andthemeanmaximaldesaturationwas 17.4% ± 11.4%(Fig2). 
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Fig 2—Distribution of maximal sleep desaturation abscissa: 
chcinge in SaO-, from awake supine to the lowest during sleep. 
Fig I—Distribution of basal sleep desaturation abscissa: change in 
SaO, from awake supine to the mean value during sleep. 
The maximal fall in SaO, recorded in a single patient during 
sleep was 61%, and 11 patients experienced SaO, less than 50% 
during sleep. All patients experienced desaturation at some time 
during sleep (Fig 2). More frequent episodes of desaturation of 
> 10% occurred in patients with severe desaturation. The mean 
frequency of SaO, dips > 10% per night was 7.6 in patients with 
severe maximal desaturation compared to 1 for patients with 
mild maximal desaturation (P < 0.001). The frequency was 5.9 
in those with severe basal desaturation and 2.5 if basal desatura-
tion was mild (P < 0.02). In 67 patients, the mean sleep SaO, 
was similar to or marginally greater than the awake SaO,. Al-
though the severity of desaturation varied considerably in these 
patients (Figs 1 and 2), the distribution was skewed in the direc-
tion of more severe desaturation. This abnormal distribution is 
not solely due to the shape of the oxyhemoglobin dissociation 
curve since the waking SaO, of most of our patients was at or 
near the steep portion of the curve. This finding suggests that 
some patients with COPD develop unusually severe desaturation 
during sleep. 
In 70% (92/130) of our patients, basal desaturation did not 
occur or was < 4% (Fig 1), which indicates that a marked, pro-
longed depression in SaO, during sleep does not regularly occur 
in COPD. However, at least one large dip in saturation occurred 
commonly with 66% (86/130) of the patients, demonstrating a 
maximal desaturation of greater than 10%. 
No repetitive periods of apnea were observed in any of the 
patients, nor was significant apnea documented polygraphically. 
In the 25 patients who had polygraphic studies, the SaO, de-
creased from awake in all sleep stages but was severe only in 
REM sleep. Maximal desaturation occurred during REM sleep 
in 21 of the patients who experienced this sleep stage. A more 
detailed description of the sleep data in these 25 patients was 
reported by Fleetham et al (16). 
Prediction of desaturation during sleep 
To evaluate those factors that predict the degree of desatura-
tion in sleep, both maximal and basal desaturation were cor-
related with clinical and laboratory data (Table 2). The most 
significant relationship existed between awake PaCO, and both 
measures of desaturation. The correlation was higher for max-
imal desaturation (r = 0.38, P < 0.001) than for basal desatura-
tion (r = 0.26, P < 0.003). The awake PaO, correlated with 
basal desaturation (r = -0.25, P<0.005)neariyaswellasthe 
awake PaCO, but was not useful for predicting maximal de-
saturation. Based on multiple regression analysis, the combina-
tion of PaO, and PaCO, was not significantly more predictive of 
basal and maximal desaturation than PaCO, alone. 
No relationship existed between the degree of desaturation 
and complaints of sleep disturbance which were provided by 
analysis of individual questions or the overall sleep-rest scale of 
the Sickness Impact Profile. There was also no relationship be-
tween degree of desaturation and the observations of troubled 
sleep based on responses to the KATZ Adjustment Scale admin-
istered to relatives of the patients. Other clinical and laboratory 
data were also unrelated to the degree of desaturation. These in-
cluded age, sex, and weight as well as analysis of measures of 
pulmonary function such as spirometry, airway resistance, func-
tional residual capacity, and physical findings such as heart and 
respiratory rate, wheezing and degree of edema, and the pres-
ence of cough or volume of sputum produced per day. 
The relationship of PaCO, to both measures of desaturation 
shows considerable scatter (Figs 3 and 4). Patients with low 
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Fig 3—Relationship between waking PaCO, and basal desatura-
tion during sleep in 130patients with hypoxemic COPD. 
Fig 4—Relationship between waking PaCO2 and maximal 
desaturation during sleep in 130 patients with hypoxemic COPD. 
PaCO, tended not to desaturate. A PaC02 ^ 40 mm Hg had high 
sensitivity but low specificity in predicting severe desaturation. 
Of the patients with severe basal desaturation (> 3%), 77% 
(37/48) had a PaCO, 5* 40 mm Hg. However, of the patients 
with mild basal desaturation ( « 3%), only 43% (35/82) had a 
PaCO, < 40 mm Hg (Fig 3). The results are slightiy better for 
predicting severe maximal desaturation (s^  17%) with a sen-
sitivity of 86.5% (45/52) and specificity of 50% (39/78) (Fig 4). 
A low PaCO, may be a useful screening tool to indicate that an 
individual is unlikely to develop severe desaturation during 
sleep. However, even this test is not generally useful to reliably 
ascertain the degree of desaturation at night. 
Significance of sleep desaturation 
We examined the complications of chronic hypoxemia to 
determine if they were more severe when marked desaturation 
occurred during sleep. A low but significant correlation (r = 
0.30, P < 0.001) occurred between basal desaturation, but not 
maximal desaturation, and the mean pulmonary artery pressure 
at rest. A low correlation also occurred between the number of 
hospitalizations in the year before the patients entered the study 
and both measures of desaturation (r = 0.20, P < 0.03). No 
relationship was observed between either measure of desatura-
tion and hematocrit, maximal exercise tolerance, the results of 
neuropsychological tests, or measures of the quality of life. 
Table 2 
Relationship Between Clinical and Laboratory Data and Desaturation During Sleep 
Maximal Desaturation Basal Desaturation 
Characteristics N Mean SD 
Correlation 
Coefficient P 
Correlation 
Coefficient P 
PaCO, (mm Hg) 129 42.7 7.5 0.381 0.001 0.262 0.003 
PaO, (mm Hg) 129 51.8 4.4 -0.104 0.24 -0.252 0.004 
pH 129 7.4 0.046 0.151 0.09 -0.122 0.17 
Age (years) 130 65.7 8.5 -0.076 0.39 0.012 0.90 
Weight (kg) 130 64.2 13.5 0.076 0.39 0.036 0.68 
FVC (% predicted) 127 53.2 18.6 -0.115 0.20 0.051 0.57 
FEV, (% predicted) 127 28.7 13.9 -0.123 0.17 0.063 0.48 
SIP sleep-rest scale 
(normal value = 2.1) 121 35.6 26.9 0.058 0.53 -0.095 0,30 
Maximal Desaturation 
Mean SD P 
Basal Desaturation 
Mean SD P 
Sex 
Male (N = 103) 
Female (N = 27) 
17.1 
18.7 
11.3 
11.7 0.52 
3.2 
4.3 
3.8 
4.6 0.19 
FEV, = forced expiratory volume in one second. FVC = forced vital capacity, SIP = Sickness Impact Profile, and SD = standard deviation. 
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Table 3 
Effect of Nocturnal Desaturation on Complications of Chronic Hypoxemia 
Mild 
Maximal Desaturation 
Severe Mild 
Basal Desaturation 
Severe 
Characteristics N * < 17% s= 17% P ss 3% > 3% P 
Number of patients 77 53 81 49 
Gas exchange 
PaO, (mm Hg) 129 52.4 50.9 0.06 52.4 50.9 0.06 
PaCOj (mm Hg) 129 40.2 46.3 < 0.001 41.3 44.9 < 0 . 0 1 
pH 129 7.41 7.39 0.02 7.41 7.40 0.31 
Pulmonary hemodynamics 
Mean pulmonary artery pressure at 
rest (mm Hg) 122 27.0 29.5 O.IO 26.7 30.2 < 0.03 
Quality of life characteristics 
Number of hospitalizations in year 
prior to entry 129 0.82 l.- i < 0.003 0.98 1,2 0.28 
Number of episodes of heart failure 
in year prior to entry 129 0.32 0.62 0.04 0.43 0.47 0.78 
Sickness Impact Profile (N = 3,1) 120 23.7 24.7 0.70 23.8 24.7 0.73 
Profile of Mood States (N = 26,4) 118 38.8 37.7 0.86 38.7 37.7 0.87 
Hematocrit (%) ]M) 47.7 47.8 0.90 47.5 48.3 0.41 
Maximal exercise tolerance (WATTS) 129 38.0 40.6 0.42 38.3 40.2 0.56 
Neuropsychological characteristics 
Global rating (N = 3,5) 123 4.2 4.4 0.35 4.2 4.4 0.30 
Halstead impairment index 
(N = 0.63) 1 IS 0.71 0.76 0.25 0.71 0.76 0.32 
Cumulative survival (%) 
Noctumal oxygen therapy 0.126 0.142 0.67 0.133 0.185 0.40 
Continuous oxygen therapy 0.099 0.098 0.60 0.084 0.117 0.88 
*N < 130 due to incomplete data. 
All entries are mean values unless otherwise indicated. 
To examine these relationships further, the severe and mild 
desaturation groups were analyzed for differences in severity of 
hypoxia-induced complications (Table 3). Pulmonary hyperten-
sion was more severe in patients with severe desaturation during 
sleep (Table 3). This difference was significant only for the basal 
desaturation determination. The mean pulmonary artery pres-
sure in the group with severe basal desaturation was only 3.5 
mm Hg higher than in those with mild basal desaturation. Al-
though patients with severe maximal desaturation had less 
severe abnormalities of pulmonary hemodynamics than patients 
with severe basal desaturation, they had significantly more hos-
pitalizations in the year preceding entry into the study. This was 
due to more frequent hospitalizations for episodes of right heart 
failure. No differences were noted in hospitalization rates or 
heart failure between the patients with severe and those with 
mild basal desaturation. 
The severity of desaturation had no effect on other manifesta-
tions of chronic hypoxemia such as erythrocytosis, exercise in-
tolerance, neuropsychological impairment as measured by the 
Halstead-Reitan battery of tests, or the quality of life as mea-
sured by the Sickness Impact Profile and the Profile of Mood 
States. There was also no effect on individual scales in each of 
these tests. 
The awake PaCO, was significantly higher in patients with se-
vere desaturation, but this was well compensated, as manifested 
by similar pH values in both groups. The hypercarbia resulted 
in a slightly lower PaO, for patients with severe desaturation. 
Because of these differences in waking blood gases, the effect of 
basal desaturation on pulmonary artery pressure was further ex-
amined by analysis of covariance to control for differences in 
PaO, or PaCO,. After adjustments were made for waking 
PaCO,, patients with severe basal desaturation still had signifi-
cantly higher adjusted mean values for pulmonary artery pres-
sure at rest (30 versus 26.9 mm Hg, P < 0.05). However, after 
adjustments were made for waking PaO,, the adjusted mean pul-
monary artery pressure at rest was 29.7 mm Hg in patients with 
severe baseline desaturation and 27.1 mm Hg in those with mild 
baseline desaturation (P < 0.08). 
Effect of desaturation in selected patients 
The effect of basal desaturation on waking pulmonary artery 
pressure was determined in a group of 53 patients with a waking 
PaO, between 54 and 59 mm Hg (Table 4). Of these, 15 had se-
vere basal desaturation (> 3%) and mean arterial blood gases 
similarto the 38 with mild basal desaturation (=£ 3%). Their 
mean pulmonary artery pressure was 3.7 mm Hg higher than 
that of the patients with less severe noctumal desaturation, but 
these differences were not significant in this group of patients. 
In another group, 20 patients with the most severe noctumal 
desaturation (basal desaturation > 6%) were compared to UO 
patients with less severe desaturation (Table 4). Their mean PaO, 
was similar to and the mean PaCO, was higher than that of 
patients with less severe desaturation. Their mean pulmonary 
artery pressure was significantly higher than that of the patients 
with less severe nocturnal desaturation. No significant dif-
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Table 4 
Effect of Nocturnal Desaturation on Pulmonary Hemodynamics 
in Select Patient Populations 
Characteristic 
Very Severe Desaturation 
Basal Desaturation 
N 6% > 6% 
Waking PaO, 54-59 mm Hg 
Basal Desaturation 
3% 
Number of patients 110 20 38 15 
Gas exchange 
PaO, (mm Hg) 129 52.1 50.5 0.16 53 55.6 56.4 0.14 
PaCO, (mm Hg) 129 41.8 47.2 0.003 53 41.5 42.2 0.73 
pH 129 7.41 7.39 0.19 5.1 7.41 7.41 0.94 
Pulmonary artery 
pressure at rest (mm Hg) 123 27.2 32.9 0.008 51 24.3 28.0 0.16 
All entries are mean values unless otherwise indicated. 
ferences in the severity of other hypoxia-induced complications 
were found. The 25 polygraphically monitored patients were 
analyzed separately. No significant correlations were found 
between hypoxia-induced complications and either measure 
of desaturation. 
Mortality 
The presence of severe desaturation in patients, obtained 
while they were breathing room air, was not a predictor of subse-
quent mortality while they were receiving home oxygen ther-
apy. This therapy included the use of oxygen during sleep in all 
cases. Since the type of oxygen therapy has been shown to affect 
mortality (10), before we calculated survival rates the patients 
were separated into two groups based on the type of therapy they 
were receiving (noctumal versus continuous). After a follow-up 
period of at least 12 months (mean 19.3 months), the life table 
cumulative survival rates were similar for patients with mild 
and severe desaturation (Table 3). The initiation of treatment 
would affect any influence that desaturation would have on mor-
tality. This finding merely indicates that severe noctumal desat-
uration prior to therapy does not predict a poor response to 
oxygen therapy. 
Discussion 
The degree of sleep arterial oxygen desaturation did not differ 
between our two groups of patients with and without poly-
graphic recordings (Table 1). Although we did not document 
sleep by EEG in all patients, it is reasonable to assume that these 
patients did in fact sleep. For this reason, we believe the two 
groups could be combined to examine relationships between 
sleep desaturation and other physiological variables. Our pa-
tients slept an average of three to four hours, and 21 of the 25 
polygraphically monitored patients demonstrated REM sleep. 
These conditions are adequate to document typical sleep 
desaturation in this population. 
Complications of chronic hypoxemia such as erythrocytosis, 
exercise intolerance, brain dysfunction, and impaired life qual-
ity as measured by standardized questionnaires were not aggra-
vated by noctumal desaturation. Similarly, no relationship was 
observed between the maximal desaturation during sleep and 
waking pulmonary hypertension. Patients with severe maximal 
desaturation also had more frequent SaO, dips > 10%. This in-
dicates that these isolated physiologic challenges are of insuffi-
cient duration to produce permanent hemodynamic changes. 
This is not surprising since these brief, dramatic events occur 
exclusively in REM sleep which comprises a minor fraction (2% 
to 5%) of the day for patients with COPD (16-18). 
The mean level of SaO, prevailing throughout sleep is proba-
bly more relevant to the development of sustained pulmonary 
hypertension since the pulmonary vasculature is exposed to this 
SaO, for a longer period. This average desaturation throughout 
sleep was examined as the basal desaturation. A correlation was 
found between basal desaturation and pulmonary artery pres-
sure. However, two factors should be considered in evaluating 
this relationship and attempting to determine if there is an in-
dependent effect of basal desaturation on waking pulmonary 
hypertension. The degree of basal desaturarion is related to 
the waking PaO, (Table 2): the lower the waking PaO,, the more 
severe the basal desaturation during sleep. Since all ofthese 
patients had waking hypoxemia which could produce pulmo-
nary hypertension alone, an independent effect of noctumal de-
saturation may be difficult to determine. The group with severe 
basal desaturation (Table 3) had a mean waking pulmonary ar-
tery pressure only 3.5 mm Hg higher than that of the patients 
with mild desaturation, but this difference was not signifi-
cant after adjusting for the waking PaO, difference in these 
two groups. 
These results also apply to patients with moderate waking hy-
poxemia (PaO, 54 to 59 mm Hg). These patients would be 
expected to be more susceptible to noctumal desaturation since 
they have less pulmonary hypertensive stimulus during waking 
hours. Finally, in the 20 patients with the most severe basal de-
saturation (> 6%), we found their mean pulmonary artery pres-
sure to be significantly higher (5.7 mm Hg) than that of patients 
with less severe desaturation. This suggests that at some degree 
of severity nocturnal desaturation can aggravate hypoxemia-
induced pulmonary hypertension. 
The lack of a significant relationship between noctumal de-
saturation and waking pulmonary hypertension is surprising. 
Numerous studies have confirmed that in awake patients with 
COPD a close relationship exists between chronic hypoxemia 
and pulmonary hypertension. By combining data from several 
reports, Burrows (19) demonstrated that mean pulmonary artery 
pressure progressively increases as waking SaO, falls below 
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Table 5 
Nocturnal Desaturation in Chronic Obstructive Pulmonary Disease 
Mean Mean Mean 
Number of Waking Mean Maximal Basal 
Patients SaO, PaCO, Desaturation Desaturation 
Reference and Type (%) (mm Hg) (%) (%) 
Flick and Block (4) 10 IPD 95 — 26 — 
Wynne et al (5) 7 IPD/OPD 89 41) 17 
— 
Douglas et al (6) I2 0PD 83 53 30 
— 
Littneret al (22) 9 0PD 91 42 15 
— 
DeMarco et al (23) 4 BB 81 4') 30 3.2 
6 PP 92 37 5 0 
Calverly et al(18) 13 BB SO 51 41 9 
7 PP 94 36 16 2.1 
NOTT (10) 130 OPD 86 43 17 3 
IPD = hospitalized subjects, OPD 
noctumal oxygen therapy trial. 
ambulatory subjects. BB = "blue bloater," PP = "pink puffer," and NOTT = 
85%. Moreover, periodic episodes of desaturation during sleep 
in COPD (8,9) as well as in sleep apnea (20) have been shown to 
produce transient increases in pulmonary artery pressure. It has 
also been postulated that nocturnal desaturation may produce 
sustained pulmonary hypertension and cor pulmonale (21), Al-
though we did not measure pulmonary artery pressure during 
sleep, the mean wake saturation of our patients was in the range 
defined by a relationship between pulmonary hypertension and 
SaO,. It is reasonable to assume that our patients with lower 
SaO, during sleep had greater increases in pulmonary artery 
pressure during sleep. However, our results show that transient 
changes in saturation and associated pulmonary hypertension 
during sleep usually do not produce chronic hemodynamic 
changes in severe COPD beyond the effect attributable to the 
daytime level of desaturation. 
These results may not apply to noctumal desaturation in other 
disorders such as sleep apnea and in COPD with borderline 
hypoxemia (PaO, > 60 mm Hg). Since patients with these 
disorders generally do not have a sustained pulmonary hyperten-
sive effect during waking hours, they may be more susceptible 
to chronic hemodynamic changes produced by basal desat-
uration during sleep. Nevertheless, our results indicate that 
more work is necessary in this area before concluding that noc-
turnal desaturation alone will produce sustained pulmonary 
hypertension. 
Patients with severe maximal desaturation had more hospi-
talizations and episodes of right heart failure. These patients 
also had more frequent dips in saturation greater than 10%. Tran-
sient episodes of pulmonary hypertension associated with these 
dips might have had an adverse effect on right ventricular func-
tion that produced more severe right ventricular hypertrophy. 
However, left ventricular dysfunction that produced greater 
lability in noctumal saturation may have been more common in 
patients with severe maximal desaturation. Since this group did 
not have more severe waking pulmonary hypertension, this find-
ing is difficult to explain. 
Our results demonstrate that marked desaturation during 
sleep is unusual in an unselected population of stable patients 
with severe hypoxemic COPD. The mean basal desaturation was 
only 3.4% ± 4.0%. This is a more comprehensive measure of 
noctumal desaturation and indicates that desaturation through-
out the night is less severe than previously indicated. The wide 
difference between maximal and mean desaturation is due to se-
rious desaturation occurring mostly in the brief periods of REM 
sleep in this patient population (16). Maximal arterial oxygen 
desaturation in our patients was comparable to that reported in 
previous studies of patients with COPD (Table 5). In our study, 
the mean maximal desaturation was 17.4% ± 11.4%, and earlier 
reports of the mean maximal desaturation ranged from 5% to 
41% (4-6,18,22,23). Since similar recording techniques were 
used in all of these studies, the great variability in degree of 
sleep arterial oxygen desaturation is probably related to 
differences in patient population in terms of clinical stability, 
severity of hypercarbia, and proportion of "blue bloater"-
type patients. 
None of our patients demonstrated significant periodic apnea 
or the characteristic features of the sleep apnea syndrome such 
as hypersomnolence and frequent arousals (24). This is consis-
tent with earlier reports (4-6,22) in which only two of 28 pa-
tients with COPD demonstrated significant obstmctive apnea, 
but it conflicts with the data of Guilleminault et al (7) who found 
significant apnea in 23 of 26 patients with COPD. However, the 
unusual incidence of sleep apnea in their patients may be be-
cause they were referred primarily for evaluation of a sleep dis-
order and were unusually obese (mean weight 96 kg) for patients 
with severe COPD. 
Previous studies of sleep and breathing in normal subjects 
have demonstrated that oxygen desaturation or irregular 
breathing during sleep is more severe in men and increases with 
age and weight (25-27). However, we found no such relationship 
in our subjects, possibly because patients with severe obstruc-
tive lung disease are a more homogeneous group of elderly, thin 
people. Only four patients were under 50 years old, and only 14 
were greater than 130% of their ideal weight. Also, all except 
one of our female patients were postmenopausal, and breathing 
during sleep in postmenopausal women may be similar to that of 
men (28). Complaints of sleep disturbance were also unrelated 
to the degree of desaturation during sleep. Although these com-
22 Henry Ford Hosp Med J—Vol 36, No 1, !'-),XS Sleep Desaturation in Hypoxemic COPD—Conway et al 
plaints were common among our patients, as confirmed by the 
Sickness Impact Profile (sleep-rest scale, mean 35.6, normal 
2.1), the disturbance was most likely caused by factors other 
than desaturation, which could include coughing, hypercarbia 
not associated with significant desaturation, effects of medica-
tion, and other chronic disease. Arousals in the patients are 
common and often unassociated with significant desaturation, 
which supports this explanation (16). 
The awake PaO, and PaCO, were the only clinical or labora-
tory tests associated with sleep desaturation. Even these tests 
were not reliable as a generally useful tool for predicting the de-
gree of noctumal desaturation (Figs 3 and 4). The PaCO, relation 
was a permissive one, that is, patients with low PaCO, usually 
do not have severe desaturation, whereas patients with a higher 
PaCO, may or may not have severe desaturation. Sleep desatura-
tion has a similar relationship to the hypercapnic drive to breathe 
(29). Patients with high hypercapnic drive generally do not have 
large dips in SaO,. Those with low drive had either littie de-
saturation or severe desaturation, although all those with severe 
desaturation had low drives. This is consistent with the notion 
that low hypercapnic drives do not cause sleep desaturation but 
permit the process which causes desaturation to occur. 
In stable patients with chronic hypoxemia and severe COPD, 
the following four conclusions can be made: 1) the mean noctur-
nal desaturation is mild in most patients; 2) desaturation during 
sleep does not aggravate hypoxia-induced polycythemia, exer-
cise intolerance, or neurophysiological impairment; 3) waking 
pulmonary hypertension is increased by noctumal desaturation, 
but this effect is clinically and statistically significant in only a 
few patients with very severe decreases in mean saturation dur-
ing sleep (> 6%); and 4) although the awake PaOj and PaCO, 
were the only clinical parameters associated with sleep desatura-
tion, even these tests were not reliable predictors of noctumal 
desaturation; however, a low PaCO, indicates that severe 
desaturation during sleep is unlikely. 
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